Assessing the Impact of the COVID-19 Pandemic on Childhood Arterial Ischemic Stroke: An Unanticipated Natural Experiment.

IF 7.8 1区 医学 Q1 CLINICAL NEUROLOGY
Heather J Fullerton, Nancy K Hills, Max Wintermark, Nomazulu Dlamini, Christine K Fox, Dana D Cummings, Timothy J Bernard, Lauren A Beslow, Lisa R Sun, Charles Grose, Phillp J Norris, Clara Di Germanio
{"title":"Assessing the Impact of the COVID-19 Pandemic on Childhood Arterial Ischemic Stroke: An Unanticipated Natural Experiment.","authors":"Heather J Fullerton, Nancy K Hills, Max Wintermark, Nomazulu Dlamini, Christine K Fox, Dana D Cummings, Timothy J Bernard, Lauren A Beslow, Lisa R Sun, Charles Grose, Phillp J Norris, Clara Di Germanio","doi":"10.1161/STROKEAHA.124.049909","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The VIPS (Vascular Effects of Infection in Pediatric Stroke) II prospective cohort study aimed to better understand published findings that common acute infections, particularly respiratory viruses, can trigger childhood arterial ischemic stroke (AIS). The COVID-19 pandemic developed midway through enrollment, creating an opportunity to assess its impact.</p><p><strong>Methods: </strong>Twenty-two sites (North America, Australia) prospectively enrolled 205 children (aged 28 days to 18 years) with AIS from December 2016 to January 2022, including 100 cases during the COVID-19 pandemic epoch, defined here as January 2020 to January 2022. To assess background rates of subclinical infection, we enrolled 100 stroke-free well children, including 39 during the pandemic. We measured serum SARS-CoV-2 nucleocapsid total antibodies (present after infection, not vaccination; half-life of 3-6 months). We assessed clinical infection via parental interview.</p><p><strong>Results: </strong>The monthly rate of eligible AIS cases declined from spring through fall 2020, recovering in early 2021 and peaking in the spring. The prepandemic and pandemic cases were similar except pandemic cases had fewer clinical infections in the prior month (17% versus 30%; <i>P</i>=0.02) and more focal cerebral arteriopathy (20% versus 11%; <i>P</i>=0.09). Among pandemic cases, 26 of 100 (26%) had positive antibodies, versus 4 of 39 (10%) of pandemic-era well children (<i>P</i>=0.04). The first SARS-CoV-2 positive case occurred in July 2020. Ten of the 26 (38%) positive cases had a recent infection by parental report, and 7 of those 10 had received a diagnosis of COVID-19. Only 1 had multisystem inflammatory syndrome in children. Median (interquartile range) nucleocapsid IgG total levels were 50.1 S/CO (specimen to calibrator absorbance ratio; 26.9-95.3) in the positive cases and 18.8 (12.0-101) in the positive well children (<i>P</i>=0.33).</p><p><strong>Conclusions: </strong>The COVID-19 pandemic may have had dual effects on childhood AIS: an indirect protective effect related to public health measures reducing infectious exposure in general, and a deleterious effect as COVID-19 emerged as another respiratory virus that can trigger childhood AIS.</p>","PeriodicalId":21989,"journal":{"name":"Stroke","volume":" ","pages":""},"PeriodicalIF":7.8000,"publicationDate":"2025-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Stroke","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1161/STROKEAHA.124.049909","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The VIPS (Vascular Effects of Infection in Pediatric Stroke) II prospective cohort study aimed to better understand published findings that common acute infections, particularly respiratory viruses, can trigger childhood arterial ischemic stroke (AIS). The COVID-19 pandemic developed midway through enrollment, creating an opportunity to assess its impact.

Methods: Twenty-two sites (North America, Australia) prospectively enrolled 205 children (aged 28 days to 18 years) with AIS from December 2016 to January 2022, including 100 cases during the COVID-19 pandemic epoch, defined here as January 2020 to January 2022. To assess background rates of subclinical infection, we enrolled 100 stroke-free well children, including 39 during the pandemic. We measured serum SARS-CoV-2 nucleocapsid total antibodies (present after infection, not vaccination; half-life of 3-6 months). We assessed clinical infection via parental interview.

Results: The monthly rate of eligible AIS cases declined from spring through fall 2020, recovering in early 2021 and peaking in the spring. The prepandemic and pandemic cases were similar except pandemic cases had fewer clinical infections in the prior month (17% versus 30%; P=0.02) and more focal cerebral arteriopathy (20% versus 11%; P=0.09). Among pandemic cases, 26 of 100 (26%) had positive antibodies, versus 4 of 39 (10%) of pandemic-era well children (P=0.04). The first SARS-CoV-2 positive case occurred in July 2020. Ten of the 26 (38%) positive cases had a recent infection by parental report, and 7 of those 10 had received a diagnosis of COVID-19. Only 1 had multisystem inflammatory syndrome in children. Median (interquartile range) nucleocapsid IgG total levels were 50.1 S/CO (specimen to calibrator absorbance ratio; 26.9-95.3) in the positive cases and 18.8 (12.0-101) in the positive well children (P=0.33).

Conclusions: The COVID-19 pandemic may have had dual effects on childhood AIS: an indirect protective effect related to public health measures reducing infectious exposure in general, and a deleterious effect as COVID-19 emerged as another respiratory virus that can trigger childhood AIS.

评估COVID-19大流行对儿童动脉缺血性卒中的影响:一项意外的自然实验。
背景:VIPS(儿童卒中感染的血管效应)II前瞻性队列研究旨在更好地理解已发表的研究结果,即常见的急性感染,特别是呼吸道病毒,可引发儿童动脉缺血性卒中(AIS)。COVID-19大流行在入学期间出现,为评估其影响创造了机会。方法:在2016年12月至2022年1月期间,22个地点(北美、澳大利亚)前瞻性纳入205名患有AIS的儿童(年龄28天至18岁),其中包括2019冠状病毒病大流行时期的100例病例,这里定义为2020年1月至2022年1月。为了评估亚临床感染的背景率,我们招募了100名无卒中儿童,包括39名大流行期间的儿童。我们测量了血清SARS-CoV-2核衣壳总抗体(感染后存在,而不是接种疫苗后存在;半衰期3-6个月)。我们通过父母访谈评估临床感染情况。结果:2020年春季至秋季,每月符合条件的AIS病例率下降,2021年初恢复,春季达到峰值。大流行前和大流行病例相似,但大流行病例在前一个月的临床感染较少(17%对30%;P=0.02)和更多局灶性脑动脉病变(20% vs 11%;P = 0.09)。在大流行病例中,100例中有26例(26%)抗体阳性,而大流行时期的39例儿童中有4例(10%)抗体阳性(P=0.04)。第一例SARS-CoV-2阳性病例发生在2020年7月。26例阳性病例中有10例(38%)最近被父母报告感染,其中7例被诊断为COVID-19。只有1例儿童有多系统炎症综合征。中位数(四分位数范围)核衣壳IgG总水平为50.1 S/CO(样品与校准器吸光度比;阳性组为26.9 ~ 95.3),阳性组为18.8(12.0 ~ 101),差异有统计学意义(P=0.33)。结论:2019冠状病毒病大流行可能对儿童AIS产生了双重影响:与一般减少感染暴露的公共卫生措施相关的间接保护作用,以及随着COVID-19作为另一种可引发儿童AIS的呼吸道病毒出现而产生的有害影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Stroke
Stroke 医学-临床神经学
CiteScore
13.40
自引率
6.00%
发文量
2021
审稿时长
3 months
期刊介绍: Stroke is a monthly publication that collates reports of clinical and basic investigation of any aspect of the cerebral circulation and its diseases. The publication covers a wide range of disciplines including anesthesiology, critical care medicine, epidemiology, internal medicine, neurology, neuro-ophthalmology, neuropathology, neuropsychology, neurosurgery, nuclear medicine, nursing, radiology, rehabilitation, speech pathology, vascular physiology, and vascular surgery. The audience of Stroke includes neurologists, basic scientists, cardiologists, vascular surgeons, internists, interventionalists, neurosurgeons, nurses, and physiatrists. Stroke is indexed in Biological Abstracts, BIOSIS, CAB Abstracts, Chemical Abstracts, CINAHL, Current Contents, Embase, MEDLINE, and Science Citation Index Expanded.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信